Skip to main content
Springer Nature Link
Log in

Human TTC5, a novel tetratricopeptide repeat domain containing gene, activates p53 and inhibits AP-1 pathway

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The transcription factor p53 and AP-1 play an important role in cellular proliferation, transformation and death. In this study, we investigated the role of a novel human gene, TTC5 (tetratricopeptide repeat domain 5), in the regulation of cell signaling pathway and cell viability. TTC5 is a member of the TTC family of proteins and has previously been shown to participate in cellular stress response. Here we demonstrate for the first time that TTC5 significantly activates p53 pathway and inhibits AP-1 transcriptional activity. Further investigation revealed that overexpression of TTC5 up-regulated p53 and p21 expression, and significantly inhibited transcriptional activity, expression and phosphorylation of c-Jun. As for the upstream of signaling pathway of AP-1, our study demonstrated that overexpression of TTC5 significantly down-regulated the expression and phosphorylation of JNK/SAPK. Moreover, overexpression of TTC5 repressed cell proliferation and induced S phase cell cycle arrest. These results indicated that TTC5 may regulate cell viability by p53 and AP-1 signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. Levine AJ, Hu W, Feng Z (2006) The p53 pathway: what questions remain to be explored? Cell Death Differ 13:1027–1036

    Article  PubMed  CAS  Google Scholar 

  2. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129–157

    PubMed  CAS  Google Scholar 

  3. Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R, Colburn N (1999) Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A 96:9827–9832

    Article  PubMed  CAS  Google Scholar 

  4. Li JJ, Westergaard C, Ghosh P, Colburn NH (1997) Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 57:3569–3576

    PubMed  CAS  Google Scholar 

  5. Bode AM, Dong Z (2000) Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 1:181–188

    Article  PubMed  CAS  Google Scholar 

  6. Lamb JR, Tugendreich S, Hieter P (1995) Tetratrico peptide repeat interactions: to TPR or not to TPR? Trends Biochem Sci 20:257–259

    Article  PubMed  CAS  Google Scholar 

  7. Demonacos C, Krstic-Demonacos M, La Thangue NB (2001) A TPR motif cofactor contributes to p300 activity in the p53 response. Mol Cell 8:71–84

    Article  PubMed  CAS  Google Scholar 

  8. Davies L, Paraskevopoulou E, Sadeq M, Symeou C, Pantelidou C, Demonacos C, Krstic-Demonacos M (2011) Regulation of glucocorticoid receptor activity by a stress responsive transcriptional cofactor. Mol Endocrinol 25:58–71

    Article  PubMed  CAS  Google Scholar 

  9. Farnebo M, Bykov VJ, Wiman KG (2001) The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 396:85–89

    Article  Google Scholar 

  10. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF (1999) Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 13:607–619

    Article  PubMed  CAS  Google Scholar 

  11. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704

    Article  PubMed  CAS  Google Scholar 

  12. Passegue E, Wagner EF (2000) JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J 19:2969–2979

    Article  PubMed  CAS  Google Scholar 

  13. Hennigan RF, Stambrook PJ (2001) Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. Mol Biol Cell 12:2352–2363

    Article  PubMed  CAS  Google Scholar 

  14. Yunlei Z, Zhe C, Yan L, Pengcheng W, Yanbo Z, Le S, Qianjin L (2013) INMAP, a novel truncated version of POLR3B, represses AP-1 and p53 transcriptional activity. Mol Cell Biochem 374:81–89

    Article  PubMed  Google Scholar 

  15. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390–2400

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National High Technology Research and Development Program (863 Program) of China (2012AA020303), the National Natural Science Foundation of China (30900741), and the Key National S&T Program “Major New Drug Development” (2009ZX09503-004).

Author information

Authors and Affiliations

  1. Chinese National Human Genome Center, Beijing, 100176, China

    Ying Xiong, Weiwei Deng & Taiping Shi

  2. Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing, 100050, China

    Lan Wang & Junzhi Wang

Authors
  1. Ying Xiong
    View author publications

    Search author on:PubMed Google Scholar

  2. Lan Wang
    View author publications

    Search author on:PubMed Google Scholar

  3. Weiwei Deng
    View author publications

    Search author on:PubMed Google Scholar

  4. Junzhi Wang
    View author publications

    Search author on:PubMed Google Scholar

  5. Taiping Shi
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Junzhi Wang or Taiping Shi.

Additional information

Ying Xiong and Lan Wang have equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiong, Y., Wang, L., Deng, W. et al. Human TTC5, a novel tetratricopeptide repeat domain containing gene, activates p53 and inhibits AP-1 pathway. Mol Biol Rep 40, 6183–6188 (2013). https://doi.org/10.1007/s11033-013-2729-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2729-6

Keywords